To understand the role of epidermal growth factor receptor (EGFR) transactivation in G protein-coupled receptor (GPCR) agonist-induced signaling events, we have studied the capacity of thrombin in the activation of Gab1-SHP2 in vascular smooth muscle cells (VSMCs). Thrombin activated both Gab1 and SHP2 in EGFRdependent manner. Similarly, thrombin induced Rac1 and Cdc42 activation, and these responses were suppressed when either Gab1 or SHP2 stimulation is blocked. Thrombin also induced PAK1 activation in a time-and EGFR-Gab1-SHP2-Rac1/Cdc42-dependent manner. Inhibition of activation of EGFR, Gab1, SHP2, Rac1, Cdc42, or PAK1 by pharmacological or genetic approaches attenuated thrombin-induced VSMC stress fiber formation and motility. Thrombin activated RhoA in a time-dependent manner in VSMCs. LARG, a RhoA-specific GEF (guanine nucleotide exchange factor), was found to be associated with Gab1 and siRNA-mediated depletion of its levels suppressed RhoA, Rac1 and PAK1 activation. Dominant negative mutant-mediated interference of RhoA activation inhibited thrombin-induced Rac1 and PAK1 stimulation in VSMCs and their stress fiber formation and migration. Balloon injury induced PAK1 activity and interference with its activation led to attenuation of SMC migration from media to intima, resulting in reduced neointima formation and increased lumen size. Inhibition of thrombin signaling by recombinant hirudin also blocked balloon injury-induced EGFR tyrosine phosphorylation and PAK1 activity. These results show that thrombin-mediated PAK1 activation plays a crucial role in vascular wall remodeling and it could be a potential target for drug development against these vascular lesions.
T hrombin elicits both mitogenic and motogenic actions in a variety of cell types, including vascular smooth muscle cells (VSMCs). [1] [2] [3] [4] [5] Thrombin mediates its effects via G protein-coupled protease-activated receptors (PARs), specifically the high-affinity receptor PAR-1. 3, 4, 6 In addition, thrombin-induced mitogenic and motogenic effects exhibit a requirement for transactivation of receptor tyrosine kinases (RTKs) such as epidermal growth factor receptor (EGFR), fibroblast growth factor receptor (FGFR)-1, and insulin-like growth factor I receptor in various cell types, including VSMCs. [7] [8] [9] [10] [11] Furthermore, it was reported that transactivation of RTKs, particularly EGFR by G protein-coupled receptor (GPCR) agonists, is sufficient in the propagation of signaling events downstream to receptor activation. 12, 13 In this aspect, studies from others as well as our laboratory showed that transactivation of EGFR by thrombin leads to stimulation of extracellular signal-regulated kinases (ERKs) and phosphatidylinositol-3 kinase (PI3K). 2, 13 However, it is less clear the extent to which RTK transactivation, eg, EGFR, by GPCR agonists such as thrombin, leads to activation of signaling events that are otherwise stimulated in response to a true ligand-induced RTK activation. One of the signaling events that is activated upon EGFR tyrosine phosphorylation is the recruitment of Gab1 (Grb2-associated binder 1) and its associated phosphatase SHP2 onto the receptor. 14, 15 Using tissue-specific knockout or knock-in mouse models, many studies have shown that Gab1-SHP2 plays a crucial role in a variety of cellular functions including cell proliferation and migration. 15, 16 Although a large number of studies have reported activation of EGFR by thrombin, it is less clear whether this GPCR agonist possess the capacity to activate Gab1/SHP2. Furthermore, the role of Gab1/SHP2 in the activation small GTPases such as Rac1/Cdc42 and their downstream target PAK1 is also not known. To test this, we have studied thrombin effects on Gab1-SHP2 activation and their involvement in Rac1/ Cdc42-mediated PAK1 stimulation in VSMCs. We found that thrombin activates PAK1 via a signaling involving EGFR, Gab1/SHP2, LARG, RhoA and Rac1 as well as Cdc42 in VSMCs. Thrombin-induced PAK1 activation was also found to be crucial in mediating vascular wall remodeling in response to injury. In addition, phosphorylation of Thr423 but not Ser144 of PAK1 was observed to be correlated with its kinase activity in VSMCs in response to thrombin and in the artery in response to injury.
Materials and Methods

Methods
Isolation of rat VSMCs, Western blot analysis, rat carotid artery balloon injury (BI) , in vitro and in vivo VSMC migration, and immunohistochemistry were performed as described previously. 17 All of the animal protocols were performed in accordance with the Thrombin stimulates Gab1 and SHP2 tyrosine phosphorylation in EGFR tyrosine kinase-dependent manner in VSMCs. A through C, An equal amount of protein from control and each time point of thrombin-treated (0.5 U/mL) VSMCs was immunoprecipitated with anti-Gab1, anti-SHP2, or anti-EGFR antibodies, and the immunoprecipitates were analyzed by Western blotting using anti-PY20 antibodies. The blots were sequentially reprobed with anti-SHP2 and anti-Gab1 antibodies (A); anti-Gab1 and anti-SHP2 antibodies (B); and anti-Gab1, anti-SHP2, and anti-EGFR antibodies in (C). D, An equal amount of protein from VSMCs that were treated with and without thrombin (0.5 U/mL) in the presence and absence of AG1478 (500 nmol/L) for 30 minutes was immunoprecipitated with anti-Gab1 antibodies, and the immunoprecipitates were analyzed by Western blotting using anti-PY20 antibodies. The blot was sequentially reprobed with anti-SHP2 and anti-Gab1 antibodies. The bar graphs represent meanϮSD values of 3 independent experiments. *PϽ0.01 vs control; **PϽ0.01 vs thrombin treatment alone.
relevant guidelines and regulations approved by the Internal Animal Care & Use Committee of the University of Tennessee Health Science Center.
Statistics
Data analysis for statistical significance of variance was performed by Student's t test.
An expanded Materials and Methods section is available in the online data supplement at http://circres.ahajournals.org.
Results
To understand the mechanisms by which thrombin induces VSMC migration, we have tested the role of Gab1 and SHP2. Thrombin at 0.5 U/mL induced tyrosine phosphorylation of Figure 2 . Thrombin-induced VSMC F-actin stress fiber formation and motility require activation of Gab1, SHP2, and EGFR. A, VSMCs that were transduced with Ad-green fluorescent protein (Ad-GFP) (control), Ad-dnGab1, or Ad-dnSHP2 with 40 mois were quiesced and treated with and without thrombin (0.5 U/mL) for 30 minutes, and F-actin stress fiber formation was measured by TRITCconjugated phalloidin staining. B, Quiescent VSMCs that were treated with and without thrombin (0.5 U/mL) in the presence and absence of AG1478 (500 nmol/L) for 30 minutes were analyzed for F-actin stress fiber formation as described for A. C, Conditions were the same as in A except that after quiescence, cells were subjected to thrombin-induced (0.5 U/mL) migration using modified Boyden chamber method. D, Quiescent VSMCs were subjected to thrombin-induced (0.5 U/mL) migration in the presence and absence of 500 nmol/L AG1478 as described for C. The bar graphs represent meanϮSD values of 3 independent experiments. *PϽ0.01 vs control or Ad-GFP; **PϽ0.01 vs thrombin or Ad-GFPϩthrombin treatment alone. Gab1, as measured by immunoblotting of anti-Gab1 immunoprecipitates of control and thrombin-treated VSMCs with anti-PY20 antibodies. Increases in tyrosine phosphorylation of Gab1 were observed at 10 minutes and peaked at 30 to 60 minutes ( Figure 1A ). Sequential probing of this membrane with anti-SHP2 antibodies showed a band with molecular moss of 72 kDa whose intensities were found to be higher in thrombin-treated VSMCs as compared to control, suggesting association of SHP2 with tyrosine-phosphorylated Gab1 in response to thrombin. In a converse experiment, thrombin induced tyrosine phosphorylation of SHP2 ( Figure 1B) . To identify the upstream mechanisms of Gab1 and SHP2 tyrosine phosphorylation, we examined the role of EGFR. Thrombin induced tyrosine phosphorylation of EGFR, as measured by immunoblotting of anti-EGFR immunoprecipitates of control and thrombin-treated VSMCs with anti-PY20 antibodies ( Figure 1C ). Maximum increases in tyrosine phosphorylation of EGFR occurred at 10 minutes, and these increases were sustained at least for 2 hours. Sequential probing of this membrane with anti-Gab1 and anti-SHP2 A, An equal amount of protein from control and each time point of thrombin-treated (0.5 U/mL) VSMCs were subjected to pull-down assay using GST-PAK-conjugated Sepharose CL4B beads, and the resultant GST-PAK-bound proteins were analyzed by Western blotting for Rac1 (left) or Cdc42 (right) using their specific antibodies. The blots in the left and right images were reprobed with anti-Cdc42 and anti-Rac1 antibodies, respectively. The bottom Western blots show total levels of Rac1 and Cdc42. B, VSMCs that were transduced with Ad-GFP (control), Ad-dnGab1, or Ad-dnSHP2 with 40 mois and quiesced were treated with and without thrombin (0.5 U/mL) for 30 minutes, and cell extracts were prepared and analyzed for Rac1 and Cdc42 activation as described for A. C, Quiescent VSMCs were treated with and without thrombin (0.5 U/mL) in the presence and absence of AG1478 (500 nmol/L) for 30 minutes, and cell extracts were prepared and analyzed for Rac1 and Cdc42 activation as described for A. D and E, After transduction with 40 mois of Ad-GFP, Ad-dnRac1, or Ad-dnCdc42 and quiescence, VSMCs were subjected to thrombin-induced (0.5 U/mL) F-actin stress fiber formation or cell migration as described in the legend for Figure 2A antibodies revealed their association with EGFR in tyrosine phosphorylation-dependent manner. To test whether EGFR tyrosine kinase activity is required for thrombin-induced Gab1 and SHP2 tyrosine phosphorylation and/or their association, quiescent VSMCs were treated with and without thrombin (0.5 U/mL) in the presence and absence of 500 nmol/L AG1478, a potent inhibitor of EGFR, 8 cell extracts were prepared and analyzed for Gab1 tyrosine phosphorylation. AG1478 significantly blocked thrombin-induced Gab1 tyrosine phosphorylation ( Figure 1D ). Reprobing of this membrane with anti-SHP2 antibodies revealed association of SHP2 with Gab1 in EGFR tyrosine kinase activity-dependent manner. To find the functional significance of Gab1 and SHP2 activation, we further tested their role in thrombininduced VSMC F-actin stress fiber formation and migration. Thrombin treatment caused extensive F-actin stress fiber formation, and these responses were completely blocked by adenovirus-mediated expression of dominant negative mutants of either Gab1 (dnGab1) or SHP2 (dnSHP2) ( Figure  2A) . Similarly, pretreatment with 500 nmol/L AG1478 inhibited thrombin-induced F-actin stress fiber formation ( Figure  2B ). Adenovirus-mediated expression of dnGab1 or dnSHP2 or pretreatment with AG1478 also reduced thrombin-induced VSMC migration, as measured by modified Boyden chamber method ( Figure 2C and 2D).
The Rho family of GTPases plays a role in the regulation of F-actin stress fiber formation, which is essential for cell migration and proliferation. 18 -21 To identify the downstream effector molecules of EGFR-Gab1/SHP2 signaling, we next studied the role of Rac1 and Cdc42. Quiescent VSMCs were treated with and without 0.5 U/mL thrombin for various times, and cell extracts were prepared and analyzed by pull-down assay using glutathione S-transferase (GST)-PAK Sepharose-CL4B beads, followed by immunoblotting for Rac1 or Cdc42. Thrombin induced activation of both Rac1 and Cdc42 in a time-dependent manner, with maximum effect at 30 to 60 minutes ( Figure 3A ). Expression of either dnGab1 or dnSHP2 or pretreatment with AG1478 inhibited thrombininduced Rac1 and Cdc42 activation by 80% ( Figure 3B and 3C). Interference with activation of Rac1 or Cdc42 via adenovirus-mediated expression of their dominant negative mutants (dnRac1 and dnCdc42, respectively) attenuated thrombin-induced VSMC F-actin stress fiber formation and migration ( Figure 3D and 3E ). Many studies have demonstrated that Rac1/Cdc42 target PAK1 in the mediation of cell migration. [22] [23] [24] [25] [26] Therefore, to determine whether this was the case for the role of Rac1/Cdc42, we next studied the time course effect of thrombin on activation of PAK1. Thrombin, while having no noticeable effect on Ser144 phosphorylation, induced Thr423 phosphorylation of PAK1 in a timedependent manner, with maximum effect at 30 to 60 minutes ( Figure 4A ). To confirm the activation of PAK1 by thrombin, we also measured its activity by immunocomplex kinase assay. Consistent with its effect on Thr423 phosphorylation, thrombin induced PAK1 activity in a time-dependent manner, with a near maximum increase between 30 and 60 minutes ( Figure 4B ). To test the role of PAK1 in thrombin-induced VSMC migration, cells were transduced with dnPAK1 adenovirus at 40 multiplicities of infection (mois), quiesced, treated with and without thrombin (0.5 U/mL) for appropriate time periods, and tested for PAK1 activity, F-actin stress fiber formation, and VSMC migration . Adenovirus-mediated expression of dnPAK1 suppressed thrombin-induced PAK1 activity, F-actin stress fiber formation, and VSMC migration ( Figure 4C through 4E) . To determine the mechanisms by . C, VSMCs that were transduced with Ad-GFP or Ad-dnPAK1 at 40 mois and quiesced were treated with and without thrombin (0.5 U/mL) for 30 minutes, and cell extracts were prepared and analyzed for PAK1 activity as described for B. D and E, All the conditions were the same as for C except that after quiescence cells were subjected to thrombin-induced (0.5 U/mL) F-actin stress fiber formation (D) or migration (E) as described in the legend for Figure 2A which thrombin activates PAK1, we next tested the role of EGFR-Gab1/SHP2-Rac1/Cdc42 signaling. Blockade of Gab1, SHP2, Rac1, or Cdc42 activation by adenovirusmediated expression of their respective dominant negative mutants or suppression of EGFR activity by AG1478 inhibited both thrombin-induced PAK1 Thr423 phosphorylation and its activity ( Figure 5A through 5F) .
Guanine nucleotide exchange factors (GEFs) play an important role in agonist-induced activation of GTPases. 27 To understand the mechanisms by which Gab1 mediates GTPase stimulation, we tested the role of GEFs. Coimmunoprecipitation assays revealed that LARG, a RhoA-specific GEF, 28 forms a complex with Gab1 in a time-dependent manner in response to thrombin ( Figure 6A ). In addition, siRNAmediated depletion of LARG inhibited thrombin-induced Rac1 and PAK1 activation ( Figure 6B and 6C ). Furthermore, thrombin stimulated RhoA in a time-dependent manner (Figure 6D ). Inhibition of EGFR by AG1478 or siRNA-mediated depletion of either Gab1 or LARG levels substantially reduced thrombin-induced RhoA activation ( Figure 6E through 6G). Adenovirus-mediated expression of dominant negative mutant of RhoA attenuated thrombin-induced Rac1 and PAK1 activation and stress fiber formation, resulting in reduced VSMC migration ( Figure 6H through 6K) .
To understand the role of PAK1 in vascular wall remodeling in vivo, we have examined its involvement in injuryinduced SMC migration and neointima formation. First, mechanical injury of rat carotid artery induced both Ser144 and Thr423 phosphorylation of PAK1 as early as 6 hours after injury and peaked at 12 hours after injury ( Figure 7A ). However, the steady-state levels of PAK1 were decreased by 30% to 40% at these time periods after injury as compared to Figure 5 . Gab1/SHP2 and Rac1/Cdc42 mediate thrombin-induced PAK1 activation in VSMCs. A, B, E, and F, VSMCs that were transduced with Ad-GFP, Ad-dnGab1, Ad-dnSHP2, Ad-dnRac1, or Ad-dnCdc42 at 40 mois and quiesced were treated with and without thrombin (0.5 U/mL) for 30 minutes, and cell extracts were prepared. Cell extracts containing an equal amount of protein from control and each treatment were analyzed by either Western blotting for PAK1 Thr423 phosphorylation using its specific antibodies or immunocomplex kinase assay for its activity using MBP and [␥ 32 P]-ATP as substrates. C and D, Quiescent VSMCs were treated with and without thrombin (0.5 U/mL) in the presence and absence of AG1478 (500 nmol/L) for 30 minutes, and cell extracts were prepared and analyzed for PAK1 Thr423 phosphorylation or kinase activity as described above for A and B, respectively. The bar graphs represent meanϮSD values of 3 independent experiments. *PϽ0.01 vs control or Ad-GFP; **PϽ0.01 vs thrombin or Ad-GFPϩthrombin treatment alone.
its levels in uninjured arteries. Consistent with its phosphorylation, PAK1 activity was also increased in the arteries in response to injury ( Figure 7B ). To find whether activation of PAK1 occurs in SMC, double immunofluorescence staining was performed in the cryosections of injured and uninjured arteries for SM␣-actin-and Thr423-phosphorylated PAK1. As shown in Figure 7C , double immunofluorescence staining for SM␣-actin and PAK1 Thr423 phosphorylation revealed PAK1 activation in SMC in response to injury. Adenovirus-mediated expression of dnPAK1 in the arteries suppressed only Thr423 phosphorylation of PAK1 and its activity ( Figure 8A and 8B) . Dominant negative mutant-mediated inhibition of PAK1 activation also reduced injury-induced SMC migration from medial to luminal surface and thereby attenuated neointima formation by 60%, resulting in increased luminal size ( Figure 8C and 8D) . To find the link between thrombin, EGFR and PAK1 in BI-induced vascular wall remodeling, we tested the effect of recombinant Figure 6 . Gab1 mediates thrombin-induced activation Rac1-PAK1 via recruiting LARG and stimulating RhoA in VSMCs. A, top, An equal amount of protein from control and each time period of thrombin-treated (0.5 U/mL) VSMCs was immunoprecipitated with anti-Gab1 antibodies, and the immunoprecipitates were analyzed by Western blotting using anti-LARG antibodies. The blot was reprobed with anti-Gab1 antibodies for normalization. A, bottom, All conditions were the same as in the top blot except that the proteins were immunoprecipitated with anti-LARG antibodies and the immunocomplexes were analyzed by Western blotting with anti-Gab1 antibodies. The blot was reprobed with anti-LARG antibodies for normalization. B and C, VSMCs that were transfected with control scrambled siRNA or LARG siRNA and quiesced were treated with and without thrombin (0.5 U/mL) for 30 minutes, and equal amounts of proteins were analyzed for either Rac1 activation by pull-down assay using the GST-PAK beads as described in the legend for Figure 3A or PAK1 Thr423 phosphorylation and its activity as described in the legend for Figure 4A and 4B, respectively. The bottom blot in B shows total Rac1 levels. The blot that was analyzed for PAK1 phosphorylation in C was reprobed sequentially with anti-PAK1 antibodies for normalization and anti-LARG antibodies for testing the efficacy of LARG siRNA on LARG levels. D, All of the conditions were the same as in A except that proteins were analyzed for RhoA activation by pull-down assay using GST-Rhotekin-conjugated Sepharose CL4B beads, followed by Western blot analysis using anti-RhoA antibodies. The bottom blot shows total RhoA levels. E, Quiescent VSMCs were treated with and without thrombin (0.5 U/mL) in the presence and absence of AG1478 (500 nmol/L) for 30 minutes, protein extracts were prepared and an equal amount of protein from each condition was analyzed for RhoA activation by pull-down assay. The bottom blot shows total RhoA levels. F, VSMCs that were transfected with control scrambled siRNA or Gab1 siRNA were quiesced and treated with and without thrombin (0.5 U/mL) for 30 minutes, and cell extracts were prepared and analyzed for RhoA activation by pull-down assay. The bottom blot shows total RhoA levels. G, All of the conditions were the same as in B except that the proteins were analyzed for RhoA activation by pull-down assay. H and I, VSMCs that were transduced with Ad-GFP or Ad-dnRhoA at 40 mois and quiesced were treated with and without thrombin (0.5 U/mL) for 30 minutes; cell extracts were prepared, and an equal amount of protein from each condition was analyzed for either Rac1 activation as described in B or PAK1 Thr423 phosphorylation and its activity as described in C. The bottom blot in H shows total Rac1 levels. The blot that was analyzed for PAK1 phosphorylation in I was reprobed sequentially with anti-PAK1 antibodies for normalization and anti-RhoA antibodies for showing the overexpression of dominant negative mutant of RhoA. J and K, After transduction with 40 mois of Ad-GFP or Ad-dnRhoA and quiescence, VSMCs were subjected to thrombin-induced (0.5 U/mL) F-actin stress fiber formation or cell migration as described in the legend for Figure 2A (r)-hirudin. As compared to uninjured arteries, ballooninjured arteries 16 hours after injury showed increased EGFR tyrosine phosphorylation. Intravenous administration of a bolus dose of r-hirudin (75 U) just before and 8 hours after balloon angioplasty inhibited both injuryinduced EGFR tyrosine phosphorylation and PAK1 activation ( Figure 8E ).
Discussion
The important findings of the present study are as follows. (1) Thrombin stimulated tyrosine phosphorylation of Gab1 and SHP2 in VSMCs. (2) Thrombin also induced tyrosine phosphorylation of EGFR with a time course similar to those of Gab1 and SHP2. (3) Both Gab1 and SHP2 were found to be associated with tyrosine-phosphorylated EGFR and inhibition of EGFR tyrosine kinase activity by AG1478 suppressed the phosphorylation of Gab1 and its association with SHP2. (4) Expression of dominant negative Gab1 or SHP2 or pretreatment with AG1478 attenuated thrombin-induced VSMC F-actin stress fiber formation and migration. (5) Thrombin activated both Rac1 and Cdc42 in a manner that is dependent on activation of EGFR and Gab1/SHP2 and blockade of Rac1 and Cdc42 inhibited thrombin-induced VSMC F-actin stress fiber formation and migration. (6) Thrombin stimulated Thr423 phosphorylation of PAK1 and its activity in a time-dependent manner and AG1478, and dominant negative mutants of Gab1, SHP2, Rac1, or Cdc42 reduced both PAK1 phosphorylation and activity. (7) Dominant negative PAK1 also blocked thrombin-induced VSMC F-actin stress fiber formation and migration. (8) LARG, a RhoA-specific GEF, was found to be associated with Gab1 in response to thrombin and siRNA-mediated depletion of its levels blocked thrombin-induced Rac1 and PAK1 activation. (9) Thrombin induced RhoA activation in EGFR-Gab1-LARG-dependent manner, and expression of its dominant negative mutant substantially attenuated thrombin-triggered Rac1 and PAK1 activation, F-actin stress fiber formation, and VSMC migration. (10) Balloon injury of rat carotid artery induced phosphorylation and activity of PAK1 in SMCs 6 hours after injury, and adenovirus-mediated expression of dnPAK1 suppressed BIinduced SMC migration from media to intima, resulting in reduced neointima formation. (12) Balloon injury also induced EGFR tyrosine phosphorylation. (13) Inactivation of thrombin via intravenous administration of r-hirudin suppressed BIinduced EGFR tyrosine phosphorylation and PAK1 activation. Together, these findings demonstrate that thrombin signaling involving EGFR, Gab1/SHP2, LARG, RhoA, Rac1/Cdc42, and PAK1, most likely in this axis, plays a crucial role in VSMC migration influencing vascular wall remodeling.
It is well established that activation of EGFR leads to recruitment and tyrosine phosphorylation of Gab1/SHP2. 14, 15 It is also demonstrated that the GPCR agonists lysophosphatidic acid and thrombin influence tyrosine phosphorylation of EGFR, and interference with activation of this receptor reduces the actions of these agents on cell proliferation and migration. [7] [8] [9] 12 The present results reveal that stimulation of EGFR by thrombin is sufficient to activate the signaling events downstream to the receptor. In addition to SHP2, Gab1 has been shown to recruit PI3K, and via different interacting effector molecules, it targets the development of various organs. Specifically, it was demonstrated that the recruitment of PI3K by Gab1 is essential for EGFR-mediated embryonic eyelid closure and keratinocyte differentiation, whereas Gab1 association with SHP2 is required for Met receptor function in placental development and muscle progenitor cell migration to the limbs. 15, 16 Because thrombin activation of EGFR also caused the recruitment of Gab1/SHP2 onto the receptor, it is possible that this signaling complex participates in the regulation of VSMC motility. Evidence in support of this possibility comes by the finding that activation of Gab1/ SHP2 is required for thrombin stimulation of Rac1/Cdc42, whose functions have been shown to be essential for F-actin stress fiber formation. 18 -21 The present findings also provide the first mechanistic evidence for the role of Gab1 in Rac1 activation. Specifically, Gab1 recruits LARG, a RhoAspecific GEF, 28 which, in turn, via its influence on RhoA activation, leads to stimulation of Rac1. Although an antagonism was observed between RhoA and Rac1 in some cell types in response to many agonists, 29 a potential role for RhoA in the activation of Rac1 has also been demonstrated in Swiss 3T3 fibroblasts. 30 Based on these findings, it can be further speculated that Gab1 or SHP2 via recruiting and influencing either GEFs, GTPase-activating proteins (GAPs), or guanine nucleotide dissociation inhibitors may be facili- tating Cdc42 activation by thrombin. Indeed, some reports showed that SHP2 via dephosphorylating p190-B RhoGAP mediates RhoA activation during myogenesis. 31 A large body of data suggests that Rho GTPases via influencing the regulation of F-actin stress fiber formation play an important role in the mediation of cell motility. 26 -29 In fact, our finding that disruption of EGFR-dependent Gab1/SHP2-mediated RhoA, Rac1, or Cdc42 activation signaling aborts thrombininduced VSMC F-actin stress fiber formation and migration suggests a role for this signaling axis in the regulation of GPCR agonist-induced cell motility.
Many reports showed that RhoA, Rac1, and Cdc42 play a role in the activation of PAK1. 25, 32 However, it is not known whether Gab1/SHP2 targets PAK1 in regulating either cell proliferation or migration in response to RTK or GPCR agonists. In this regard, the present study reveals that thrombin-induced Gab1/SHP2 leads to activation of PAK1. In addition, because blockade of EGFR or Gab1/SHP2 activation suppresses Rac1 and Cdc42 activation and inhibition of these GTPases attenuates PAK1 Thr423 phosphorylation and activity, it is quite likely that thrombin-induced PAK1 activation involves EGFR and the Gab1/SHP2-Rac1/ Cdc42 signaling axis and facilitates F-actin rearrangement and stress fiber formation in VSMCs, leading to their migration. Although the mechanism by which EGFR-Gab1/SHP2 leads to activation of Cdc42 remains to be explored, it appears that LARG, a RhoA-specific GEF, connects EGFR-Gab1 signaling to PAK1 activation via RhoA-dependent Rac1 stimulation. Furthermore, because no noticeable changes are observed in the Ser144 phosphorylation of PAK1 by thrombin, it is likely that EGFR-Gab1/SHP2-LARG-RhoA-Rac1/Cdc42 signaling does not affect the phosphorylation of this residue. It also appears that Ser144 phosphorylation is not required for PAK1 activity because there was no correlation between these 2 events in response to thrombin in VSMCs. It is noteworthy that adenovirus-mediated expression of kinase-dead PAK1, while enhancing Ser144 phosphorylation, reduced Thr423 phosphorylation and activity of endogenous PAK1, a finding that suggests a correlation between Thr423 phosphorylation and kinase activity. This result indicates that overexpression of kinase-dead PAK1 somehow sequesters endogenous PAK1 from being phosphorylated at Thr423 residue. It also suggests that Thr423 is present in the catalytic domain. 25 With regard to PAK1 activation in the arteries in response to injury in vivo, its levels were decreased by Ϸ30%, but its phosphorylation both at Ser144 and Thr423 and activity were increased very robustly. This finding suggests that although PAK1 levels were reduced by injury, its activity was increased by enhanced phosphorylation and this appears to be sufficient to activate its downstream signaling events necessary for SMC migration. Because downregulation of PAK1 activation significantly blocked injury-induced neointima formation, it is possible that PAK1 may also be involved in SMC multipli- Figure 8 . Blockade of PAK1 activation suppresses BI-induced SMC migration from medial-to-intimal region and neointima formation in rat carotid arteries. A and B, Immediately after BI, Ad-GFP or Ad-dnPAK1 was transduced into injured arteries at 10 10 pfu/mL. Carotid arteries were dissected out at 12 hours after BI, and tissue extracts were prepared and analyzed by either Western blotting for PAK1 Ser144/Thr423 phosphorylation using their specific antibodies (A) or immunocomplex kinase assay for its activity using MBP and [␥ 32 P]-ATP as substrates (B). C, Three days after BI, injured and uninjured common carotid arteries were dissected out, fixed, opened longitudinally, and stained with SM␣-actin antibodies, and the cells in the luminal region were counted. D, All of the conditions were the same as in C except that 2 weeks after BI, arteries were isolated and fixed, cross-sections were made and stained with hematoxylin/eosin, and morphometric analysis was performed and the I/M ratios were calculated. E, Before and soon after BI, r-hirudin was administered into animals. Injured and uninjured arteries were dissected out 16 hours after BI, and tissue extracts were prepared. The tissue extracts containing an equal amount of protein from each group were analyzed for EGFR tyrosine phosphorylation and PAK1 activation as described in the legends for Figures 1C, 4A, and 4B, respectively. The bar graphs in C and D represent meanϮSD values of SMC migration and neointima formation/lumen size, respectively. *PϽ0.05 vs Ad-GFP BI alone (nϭ6). cation in response to injury. In fact, a large body of data suggests that PAK1 plays a role in the regulation of cell growth. 33 Given the role of PAK1 in the regulation of both cell proliferation and migration, and downregulation of its activity inhibited injury-induced neointima formation, it is quite likely that PAK1 plays a crucial role in vascular wall remodeling. In addition, because downregulation of thrombin activity via r-hirudin inhibited injury-induced EGFR tyrosine phosphorylation and PAK1 activity, it is conceivable that endogenously produced thrombin activates both EGFR and PAK1 in vascular wall as well, contributing to neointima formation following angioplasty. The role of thrombin in injuryinduced neointima formation has also been reported previously, but the underlying mechanisms were not explored. 34, 35 In this aspect, the present data provide mechanistic evidence for the role of thrombin in vascular wall remodeling.
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